Michael Joseph Golembiewski - Net Worth and Insider Trading
Michael Joseph Golembiewski Net Worth
The estimated net worth of Michael Joseph Golembiewski is at least $10,374 dollars as of 2024-06-14. Michael Joseph Golembiewski is the CFO of Seelos Therapeutics Inc and owns about 10,806 shares of Seelos Therapeutics Inc (SEEL) stock worth over $10,374. Details can be seen in Michael Joseph Golembiewski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Joseph Golembiewski has not made any transactions after 2023-11-30 and currently still holds the listed stock(s).
Transaction Summary of Michael Joseph Golembiewski
Michael Joseph Golembiewski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Joseph Golembiewski owns 1 companies in total, including Seelos Therapeutics Inc (SEEL) .
Click here to see the complete history of Michael Joseph Golembiewski’s form 4 insider trades.
Insider Ownership Summary of Michael Joseph Golembiewski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SEEL | Seelos Therapeutics Inc | 2023-11-30 | Chief Financial Officer |
Michael Joseph Golembiewski Latest Holdings Summary
Michael Joseph Golembiewski currently owns a total of 1 stock. Michael Joseph Golembiewski owns 10,806 shares of Seelos Therapeutics Inc (SEEL) as of November 30, 2023, with a value of $10,374.
Latest Holdings of Michael Joseph Golembiewski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SEEL | Seelos Therapeutics Inc | 2023-11-30 | 10,806 | 0.96 | 10,374 |
Holding Weightings of Michael Joseph Golembiewski
Michael Joseph Golembiewski Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Joseph Golembiewski has made a total of 1 transactions in Seelos Therapeutics Inc (SEEL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Seelos Therapeutics Inc is the acquisition of 10,375 shares on November 30, 2023, which cost Michael Joseph Golembiewski around $100,430.
Insider Trading History of Michael Joseph Golembiewski
- 1
Michael Joseph Golembiewski Trading Performance
GuruFocus tracks the stock performance after each of Michael Joseph Golembiewski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Joseph Golembiewski is -1.59%. GuruFocus also compares Michael Joseph Golembiewski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Joseph Golembiewski within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Joseph Golembiewski's insider trading performs compared to the benchmark.
Performance of Michael Joseph Golembiewski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.32 |  | | | | |
| Relative Return to S&P 500(%) | 5.9 | | | | | |
Michael Joseph Golembiewski Ownership Network
Michael Joseph Golembiewski Owned Company Details
What does Seelos Therapeutics Inc do?
Who are the key executives at Seelos Therapeutics Inc?
Michael Joseph Golembiewski is the Chief Financial Officer of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , SVP & Chief Business Officer Neil Morton , and director & CEO & Secretary Richard W Pascoe .
Seelos Therapeutics Inc (SEEL) Insider Trades Summary
Over the past 18 months, Michael Joseph Golembiewski made 1 insider transaction in Seelos Therapeutics Inc (SEEL) with a net purchase of 83,000. Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 75,757 shares made by Raj Mehra ,
In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 19,845 shares were bought by its insiders, resulting in a net purchase of 19,845 shares.
Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seelos Therapeutics Inc Insider Transactions
Michael Joseph Golembiewski Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Joseph Golembiewski. You might contact Michael Joseph Golembiewski via mailing address: 7 Turtle Ct, Flemington Nj 08822.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
